Tartana Minerals (ASX: TAT) secures A$5.18m Xingye investment at 165% premium as board vote looms

Tartana Minerals Limited (ASX: TAT) has signed a two-tranche placement agreement under which Xingye Gold (Hong Kong) Mining Company Limited will invest approximately A$5.18 million at 5.3 cents per share. The subscription price represents a 165% premium to Tartana Minerals’ last traded price of 2 cents and a 112% premium to its 15-day volume-weighted average price. Xingye would emerge with 19.99% of the Australian explorer’s enlarged issued capital if both tranches complete, while also gaining board nomination, technical participation and future financing rights. The funding could materially accelerate exploration across Tartana Minerals’ silver, tin, copper and zinc portfolio in Far North Queensland. However, completion remains conditional on due diligence, Chinese regulatory approvals, Foreign Investment Review Board approval and the outcome of an extraordinary general meeting that could reshape the company’s board.

The transaction converts the unsolicited indicative proposal disclosed on 10 July into a binding placement agreement, subject to conditions. It also gives Xingye a second strategic platform in the Australian-listed mining sector while its Hong Kong subsidiary separately pursues an off-market takeover of Far East Gold Limited. That wider context suggests Xingye is seeking more than passive exposure to Australian mineral assets, although Tartana Minerals remains a separate transaction with its own regulatory, governance and execution conditions.

Why does Xingye’s 165% premium not mean Tartana Minerals has already received A$5.18 million?

The placement will occur through two separate issuances at 5.3 cents per share. Tranche one involves approximately 43.46 million new shares and would raise about A$2.30 million, taking Xingye’s voting interest to approximately 9.99%. Tranche two involves a further 54.33 million shares and would raise approximately A$2.88 million, increasing Xingye’s voting interest to 19.99%.

Neither amount should yet be treated as completed funding. Both tranches require Xingye to complete due diligence to its satisfaction and obtain the relevant Chinese regulatory approvals. Tranche two additionally requires approval from Australia’s Foreign Investment Review Board, while Tartana Minerals and Xingye must obtain any other regulatory, shareholder or corporate approvals applicable to each stage.

The agreement also includes customary conditions covering material adverse changes, significant corporate events and the continued ordinary-course operation of Tartana Minerals. The conditions must be satisfied or waived by 16 November 2026 unless the parties agree to extend the deadline. This gives Xingye several months to examine the company’s assets, liabilities, tenements, operational position and corporate structure before committing the full amount.

The 5.3-cent price is nevertheless significant. Tartana Minerals’ market capitalisation stood at roughly A$7 million around the announcement, while the full placement would inject cash equivalent to a large proportion of that public-market value. At the subscription price, the enlarged company would carry an implied equity value of approximately A$25.9 million based on the expected post-placement share count. That is a transaction-derived valuation rather than an independently assessed company valuation, and it remains conditional on completion.

The unusual premium may reflect Xingye’s assessment of the underlying mineral portfolio, the strategic rights attached to the agreement or the difficulty of accumulating a 19.99% interest through ordinary market purchases in a small and relatively illiquid company. It does not, by itself, establish that Tartana Minerals shares should immediately trade at 5.3 cents.

How much dilution and strategic influence will Xingye receive for its cornerstone investment?

Tartana Minerals expects to issue approximately 97.79 million new shares across the two tranches. Based on the disclosed placement mechanics, the company currently has roughly 391.4 million shares on issue and would have approximately 489.2 million after full completion, assuming no other securities are issued in the meantime.

The new shares represent approximately 25% of the pre-placement share count. Existing shareholders would continue to own their current number of shares, but their collective proportional ownership would fall to approximately 80.01% of the enlarged company. The resulting 19.99% dilution is material, although it comes at a price substantially above the prevailing market value rather than through a discounted placement.

Tartana Minerals expects to use its existing placement capacity under Australian Securities Exchange Listing Rules 7.1 and 7.1A for both tranches. That means the company does not currently expect to require a separate shareholder vote specifically approving the share issuance, although other regulatory or corporate approvals may still be necessary.

Xingye’s rights extend well beyond the shares themselves. Following completion of tranche one and satisfaction of the Foreign Investment Review Board condition, Xingye can appoint one director if Tartana Minerals has three or fewer other directors, or two directors where there are four or more. Until those appointments are made, Xingye may nominate an observer to attend board meetings.

Xingye will also receive participation rights and a right of first refusal over future equity raisings after tranche one. It has a right of first refusal over debt funding until tranche two completes, while Tartana Minerals cannot dispose of its interest in Queensland Strategic Metals Pty Limited or the subsidiary’s projects without Xingye’s consent. Several of those rights continue while Xingye maintains a holding of at least 9.5%.

These provisions make the placement a strategic partnership rather than a conventional capital raise. Tartana Minerals gains a well-funded mining investor and possible access to geologists and operational expertise. Xingye gains influence over future capital formation, board composition and the treatment of assets held through Queensland Strategic Metals.

The commercial test is whether that influence improves technical decision-making and financing access without restricting Tartana Minerals’ ability to consider competing capital providers, partnerships or asset transactions.

Why has the 17 August Tartana Minerals board vote become a condition of the Xingye agreement?

Xingye can terminate the placement agreement immediately if shareholders vote on 17 August to remove Executive Chairman Sonny Didugu and directors Michael Thirnbeck and Kiara Wang. Xingye has agreed that any placement shares issued before the extraordinary general meeting will not be voted at that meeting, meaning existing shareholders will determine the board outcome without the newly issued shares altering the result.

The termination right ties the investment directly to Tartana Minerals’ governance contest. The extraordinary general meeting includes resolutions seeking the removal of six directors, with competing groups presenting sharply different assessments of the company’s performance, capital management and strategic direction.

Sonny Didugu has argued in the meeting materials that Tartana Minerals requires an operational cost review, greater financial discipline and a stronger exploration focus. He has also called for the removal of Stephen Bartrop, Alistair Lewis and Mat Hancock while recommending that shareholders retain himself, Michael Thirnbeck and Kiara Wang. Those statements represent the position of one side in the board dispute rather than independent findings about the conduct or performance of the other directors.

Stephen Bartrop, Alistair Lewis and Mat Hancock have disputed that assessment and argued that the company is entering a more active operational and exploration phase. The meeting materials therefore present competing claims about historical spending, copper sulphate plant performance, executive remuneration and the best strategy for Tartana Minerals.

Xingye’s termination clause indicates that it has entered the agreement on the assumption that the current executive chairman and supporting directors remain in place. It does not give Xingye a vote at the extraordinary general meeting through the placement, but it gives shareholders a clear commercial consequence to consider. Removing the three nominated directors could cause the A$5.18 million agreement to terminate.

That creates a difficult governance tension. Shareholders must decide the board composition they consider appropriate while knowing that one outcome may preserve the Xingye investment and another may put it at risk. The board vote is therefore no longer only a referendum on historical performance. It has become a decision about the company’s future funding structure and strategic partner.

Where will Tartana Minerals spend the Xingye funding across its Queensland project portfolio?

Tartana Minerals has committed to directing the placement proceeds predominantly toward exploration rather than copper sulphate production. Priority areas include the Nightflower Silver Project, the Montalbion silver prospects and the Tartana mining leases, where the company is targeting copper and zinc.

The company also intends to assess tin exploration opportunities across the wider Montalbion district, including Victoria Amalgamated, Daisy Bell, De Wett, Comeno and Lady Agnes. Xingye may provide geologists at its own cost to assist with geological modelling, drill planning, exploration strategy and field execution, subject to Tartana Minerals approving the nominated personnel.

Tartana Minerals previously designed an exploration campaign involving approximately 21,000 metres of drilling across eight prospects and 82 proposed holes. Its broader tenement position covers more than 2,000 square kilometres and contains targets prospective for copper, gold, zinc, silver, tin, antimony and tungsten. The company has also been drilling the Tartana Copper Project with the objective of potentially increasing its existing estimate of approximately 45,000 tonnes of contained copper to more than 100,000 tonnes.

The placement could therefore remove one of the most immediate constraints on the exploration programme. Instead of repeatedly raising smaller amounts to fund individual campaigns, Tartana Minerals would have enough capital to prioritise multiple targets, mobilise its drilling equipment and generate a more continuous pipeline of assay results.

The decision not to allocate the Xingye proceeds to copper sulphate production is equally revealing. Tartana Minerals announced the restart of copper sulphate pentahydrate production on 9 July after installing and commissioning a replacement chiller system and undertaking additional plant work. However, the plant has experienced interruptions, including wet-season access constraints and equipment replacement, while customer receipts were nil during the March quarter.

The funding agreement effectively creates separate strategic tracks. Copper sulphate production must demonstrate that it can generate reliable operating receipts without consuming the new placement funds, while Xingye’s capital is directed toward drilling and resource expansion.

That separation may improve capital transparency. It also means the operating plant cannot rely on this placement as a financial cushion if further reliability, feed or working-capital problems emerge.

Why is A$5.18 million financially material for Tartana Minerals despite its recent capital raises?

Tartana Minerals reported only A$10,695 in cash at 31 December 2025, alongside A$5.34 million of current liabilities and net current liabilities of approximately A$5.13 million. The company recorded half-year revenue of about A$1.47 million and a net loss of A$1.80 million.

The company subsequently raised A$4.5 million through a February placement, although the funds arrived through multiple tranches. At 31 March 2026, Tartana Minerals held A$304,000 in cash after using A$665,000 in operating activities and A$206,000 in investing activities during the quarter. Its statutory cash-flow report showed estimated available funding equal to approximately 0.44 quarters of relevant expenditure at the March-quarter rate.

Management said that quarter was unusual because copper sulphate customer receipts were nil and parts of the February placement had not yet settled. Even so, the figures demonstrate why the Xingye transaction matters. A small exploration and development company with volatile operating receipts can consume capital quickly when it is simultaneously funding plant upgrades, drilling, salaries, finance costs and corporate expenditure.

The new investment could substantially extend Tartana Minerals’ exploration runway. It could also reduce the need for another near-term discounted placement, provided the transaction completes and spending is controlled.

The quality of the funding is as important as the amount. Issuing shares at 5.3 cents rather than 2 cents allows Tartana Minerals to raise A$5.18 million with materially fewer shares than would be required at the prevailing market price. Raising the same amount at 2 cents would require approximately 259 million shares, before considering fees or placement constraints.

The trade-off is strategic concentration. Xingye becomes the largest shareholder, gains financing and governance rights and may influence which projects receive priority. Tartana Minerals is effectively exchanging a meaningful degree of future flexibility for capital, technical support and a subscription price far above the market.

What does Tartana Minerals’ share price reveal about investor confidence in the deal?

Tartana Minerals shares finished 17 July at approximately 2 cents, unchanged from the reference price used in the placement announcement. The shares traded between 2 cents and 2.2 cents during the session and remained far below Xingye’s 5.3-cent subscription price. The latest available market capitalisation was approximately A$7.1 million.

The stock had traded at 3 cents when the indicative Xingye proposal was disclosed on 10 July, meaning the 17 July close was about 33% lower over that period. Against the 2.3-cent close recorded on 17 June, the shares were down approximately 13%. The available 52-week range was 1.4 cents to 5.5 cents.

The absence of an immediate move toward 5.3 cents does not necessarily mean the market dismisses the agreement. The placement is conditional, only Xingye receives the premium price and the subscription shares come with strategic rights that ordinary investors do not receive.

The market may also be applying discounts for the regulatory timeline, due diligence condition, dilution and uncertainty surrounding the August board vote. Small-cap liquidity can further limit the speed at which new information is reflected in the share price.

A stronger market rerating would probably require evidence that tranche one has completed, the extraordinary general meeting has not triggered termination and Foreign Investment Review Board approval is progressing. Exploration results would then need to show that the funding is creating geological value rather than merely extending corporate life.

What milestones will decide whether the Xingye investment creates lasting value for Tartana shareholders?

The first milestone is satisfactory completion of Xingye’s due diligence. Tartana Minerals must then secure the Chinese regulatory approvals required for tranche one and complete the initial A$2.30 million issuance.

The extraordinary general meeting on 17 August is the most immediate governance test. A vote removing Sonny Didugu, Michael Thirnbeck and Kiara Wang would give Xingye the right to terminate the agreement. Retaining them would preserve the placement pathway but would not guarantee that the remaining regulatory and due diligence conditions are satisfied.

Foreign Investment Review Board approval will be central to tranche two and Xingye’s progression to 19.99%. The board nomination and financing rights also require scrutiny because they will shape Tartana Minerals’ strategic options after the investment.

Operationally, the company must show that the proceeds are converted into drilling activity, assays, resource growth and clearer project prioritisation. The copper sulphate operation must separately demonstrate reliable production and customer receipts because the Xingye funds are not intended to support that business.

What has improved is Tartana Minerals’ access to potential funding at a substantial premium and its ability to draw on the technical capabilities of a larger mining group. What remains unresolved is whether the conditions will be met, whether the board dispute will stabilise and whether the expanded exploration programme will deliver results commensurate with the dilution and strategic rights granted.

The decisive proof will be completion of both placement tranches followed by measurable resource advancement without another rapid return to the equity market.

Key takeaways from Xingye’s A$5.18 million Tartana Minerals strategic investment

• Xingye Gold has agreed to invest approximately A$5.18 million in Tartana Minerals at 5.3 cents per share.
• The subscription price represents a 165% premium to Tartana Minerals’ last traded price and a 112% premium to its 15-day volume-weighted average price.
• Tranche one would raise approximately A$2.30 million and give Xingye a 9.99% voting interest.
• Tranche two would raise approximately A$2.88 million and increase Xingye’s holding to 19.99%.
• Existing shareholders would retain their shares but experience approximately 19.99% proportional dilution after both tranches.
• Completion remains subject to due diligence, Chinese regulatory approvals, Foreign Investment Review Board approval and other conditions.
• Xingye will receive board nomination, project consultation, future capital participation and selected asset-consent rights.
• Xingye can terminate the agreement if shareholders vote to remove Sonny Didugu, Michael Thirnbeck and Kiara Wang on 17 August.
• Placement funds are intended primarily for exploration at Nightflower, Montalbion and the Tartana copper and zinc mining leases, not copper sulphate production.
• The next measurable tests are tranche-one completion, the extraordinary general meeting outcome, Foreign Investment Review Board approval and funded drilling results.